As of January 22, 2025, Inovio Pharmaceuticals (INO) has a market cap of $81.225 million USD. According to our data, Inovio Pharmaceuticals is ranked No.7846 in global market value.
Year | Market Cap | %Change |
---|---|---|
Jan 22, 2025 | $81.23 M |
22.95%
|
Dec 31, 2024 | $66.06 M |
-70.10%
|
Dec 29, 2023 | $0.22 B |
-67.31%
|
Dec 30, 2022 | $0.68 B |
-68.74%
|
Dec 31, 2021 | $2.16 B |
-43.62%
|
Dec 31, 2020 | $3.83 B |
168.18%
|
Dec 31, 2019 | $1.43 B |
-17.50%
|
Dec 31, 2018 | $1.73 B |
-3.15%
|
Dec 29, 2017 | $1.79 B |
-40.49%
|
Dec 30, 2016 | $3.01 B |
3.27%
|
Dec 31, 2015 | $2.91 B |
-26.80%
|
Dec 31, 2014 | $3.98 B |
-20.86%
|
Dec 31, 2013 | $5.03 B |
480.00%
|
Dec 31, 2012 | $0.87 B |
16.28%
|
Dec 30, 2011 | $0.75 B |
-62.61%
|
Dec 31, 2010 | $1.99 B |
0.88%
|
Dec 31, 2009 | $1.98 B |
119.23%
|
Dec 31, 2008 | $0.90 B |
-43.48%
|
Dec 31, 2007 | $1.59 B |
-72.04%
|
Dec 29, 2006 | $5.70 B |
44.93%
|
Dec 30, 2005 | $3.93 B |
-42.39%
|
Dec 31, 2004 | $6.83 B |
-21.20%
|
Dec 31, 2003 | $8.66 B |
362.96%
|
Dec 31, 2002 | $1.87 B |
-57.81%
|
Dec 31, 2001 | $4.44 B |
-31.73%
|
Dec 29, 2000 | $6.50 B |
-71.15%
|
Dec 31, 1999 | $22.53 B |
-1.89%
|
Dec 31, 1998 | $22.96 B |
100%
|
Name | Market Cap | Market cap difference | Regions |
---|---|---|---|
Moderna
MRNA
|
$14.82 B |
-0.000 M
|
USA
|
BioNTech
BNTX
|
$27.61 B |
0.000 M
|
Germany
|
Novavax
NVAX
|
$1.41 B |
-0.000 M
|
USA
|
Pfizer
PFE
|
$147.43 B |
0.004 M
|
USA
|
GlaxoSmithKline
GSK
|
$68.21 B |
-0.002 M
|
UK
|
AstraZeneca
AZN
|
$211.49 B |
0.007 M
|
UK
|
Sanofi
SNY
|
$129.14 B |
0.001 M
|
France
|
Johnson & Johnson
JNJ
|
$349.71 B |
-0.006 M
|
USA
|
Merck
MRK
|
$242.01 B |
0.005 M
|
USA
|
Gilead Sciences
GILD
|
$115.95 B |
0.002 M
|
USA
|
Regeneron Pharmaceuticals
REGN
|
$74.73 B |
1.236 B
|
USA
|
Amgen
AMGN
|
$146.98 B |
0.004 M
|
USA
|
Eli Lilly
LLY
|
$677.80 B |
-0.006 M
|
USA
|
Market Cap | = | INO Stock Price | * | INO Shares Outstanding |
= | $2.25 | * | 36.10 M | |
= | $81.23 M |